Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News IMAC Holdings Inc BACK

IMAC Holdings, Inc. is a clinical research and commercialization company. The Company is focused on innovative medical advancements and care in the oncology, neurological, and orthopedic medical specialties. The Company is focused on providing natural, non-opioid solutions to pain as consumers demand conservative treatments for an aging population. Its Investigational New Drug division... see more

Recent & Breaking News (NDAQ:BACK)

IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

GlobeNewswire 4 days ago

IMAC Holdings Granted Extension by Nasdaq to Regain Compliance with Listing Rule 5250(c)(1)

GlobeNewswire 12 days ago

IMAC Holdings Inc. Launches Subsidiary Ignite Proteomics and Announces Groundbreaking Precision Oncology Case Study Utilizing RPPA Technology

GlobeNewswire September 19, 2024

IMAC Holdings receives notification of deficiency from Nasdaq related to delayed filing of quarterly report on Form 10-Q

GlobeNewswire August 23, 2024

IMAC Holdings, Inc. Appoints Dr. Matthew Schwartz and Dr. Peter Beitsch to Board of Directors

GlobeNewswire July 11, 2024

DayDayCook Names Jeffrey Ervin as Co-Chief Financial Officer

GlobeNewswire June 25, 2024

IMAC Holdings Announces Leadership Succession

GlobeNewswire May 24, 2024

IMAC Holdings Acquires Assets of Theralink to Continue Precision Medicine Business

GlobeNewswire May 7, 2024

Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors

GlobeNewswire February 13, 2024

Theralink® and IMAC Holdings announce receipt and response to the Securities and Exchange Commission comments on the previously filed Form S4

GlobeNewswire November 13, 2023

Theralink® Announces Promising Interim Results on the Implementation of Proteomic Analysis into Inova Schar Cancer Institute's Molecular Tumor Board

GlobeNewswire November 3, 2023

Theralink Announces Filing of Form S-4; Merger with IMAC Holdings Expected During Q4 2023

GlobeNewswire October 4, 2023

IMAC Holdings, Inc. Regains Compliance with Nasdaq Listing Requirements

GlobeNewswire September 27, 2023

IMAC Holdings, Inc. Announces 1-for-30 Reverse Stock Split

GlobeNewswire September 7, 2023

IMAC Holdings Announces $4.3 Million Private Placement of Convertible Preferred Stock and Warrants Priced at the Market

GlobeNewswire July 26, 2023

IMAC Holdings Annual Meeting of Shareholders Reminder

GlobeNewswire June 28, 2023

Theralink Technologies Appoints Faith Zaslavsky as Chief Executive Officer

GlobeNewswire June 27, 2023

Moore Kuehn Encourages VECT, EMBK, BACK, and RADI Investors to Contact Law Firm

PR Newswire May 31, 2023

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating IMAC Holdings, Inc. Merger

Newsfile May 25, 2023

BACK Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of IMAC Holdings, Inc. Is Fair to Shareholders

Business Wire May 23, 2023